The First Purine Nucleoside Phosphorylase Deficiency Patient Resembling IgA Deficiency and a Review of the Literature

References

• Abolhassani H, Aghamohammadi A, Fang M, et al. (2019). Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 21(1), 243.
   PubMed Web of Science ®Google Scholar
• Alangari A, Al-Harbi A, Al-Ghonaium A, et al. (2009). Purine nucleoside phosphorylase deficiency in two unrelated Saudi patients. Ann Saudi Med, 29(4), 309. doi:10.4103/0256-4947.55320
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Bousfiha A, Casanova J-L, et al. (2014). Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol, 5, 162.
   PubMed Web of Science ®Google Scholar
• Al-Saud B, Alsmadi O, Al-Muhsen S, et al. (2009). A novel mutation in purine nucleoside phosphorylase in a child with normal uric acid levels. Clin Biochem, 42(16–17), 1725–1727. doi:10.1016/j.clinbiochem.2009.08.017
   PubMed Web of Science ®Google Scholar
• Arvin AM, Koropchak CM, Williams BR, et al. (1986). Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis, 154(3), 422–429.
   PubMed Web of Science ®Google Scholar
• Aust MR, Andrews LG, Barrett MJ, et al. (1992 Oct). Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency. Am J Hum Genet, 51(4), 763–772.
   PubMed Web of Science ®Google Scholar
• Aytekin C, Dogu F, Tanir G, et al. (2010). Purine nucleoside phosphorylase deficiency with fatal course in two sisters. Eur J Pediatr, 169(3), 311–314. doi:10.1007/s00431-009-1029-6
   PubMed Web of Science ®Google Scholar
• Aytekin C, Yuksek M, Dogu F, et al. (2008). An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication. Pediatr Transplant, 12(4), 479–482. doi:10.1111/j.1399-3046.2007.00890.x
   PubMed Web of Science ®Google Scholar
• Baguette C, Vermylen C, Brichard B, et al. (2002). Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency. J Pediatr Hematol Oncol, 24(1), 69–71.
   PubMed Web of Science ®Google Scholar
• Bayer DK, Martinez CA, Sorte HS, et al. (2014). Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol, 178(3), 459–469. doi:10.1111/cei.12421
   PubMed Web of Science ®Google Scholar
• Blatt J. (1990). Excessive chemotherapy‐related granulocytopenia in a child with non‐Hodgkin’s lymphoma and a congenital abnormality of purine salvage. Pediatr Blood Cancer, 18(4), 329–332.
   Google Scholar
• Brodszki N, Svensson M, van Kuilenburg AB, et al. (Springer 2015). Novel genetic mutations in the first Swedish patient with purine nucleoside phosphorylase deficiency and clinical outcome after hematopoietic stem cell transplantation with HLA-matched unrelated donor. JIMD Rep, 24, 83–89. doi:10.1007/8904_2015_444
   PubMedGoogle Scholar
• Broome CB, Graham ML, Saulsbury FT, et al. (1996). Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling. J Pediatr, 128(3), 373–376.
   PubMed Web of Science ®Google Scholar
• Buckley RH. (1994). Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am, 41(4), 665–690.
   PubMed Web of Science ®Google Scholar
• Camici M, Micheli V, Ipata PL, Tozzi MG. (2010). Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem Int, 56(3), 367–378. doi:10.1016/j.neuint.2009.12.003
   PubMed Web of Science ®Google Scholar
• Celmeli F, Turkkahraman D, Uygun V, et al. (2015). A successful unrelated peripheral blood stem cell transplantation with reduced intensity‐conditioning regimen in a patient with late‐onset purine nucleoside phosphorylase deficiency. Pediatr Transplant, 19(2), E47–E50. doi:10.1111/petr.12413
   PubMed Web of Science ®Google Scholar
• Chantin C, Bonin B, Boulieu R, Bory C. (1996). Liquid-chromatographic study of purine metabolism abnormalities in purine nucleoside phosphorylase deficiency. Clin Chem, 42(2), 326–328.
   PubMed Web of Science ®Google Scholar
• Classen C, Schulz A, Sigl-Kraetzig M, et al. (2001). Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. Bone Marrow Transplant, 28(1), 93. doi:10.1038/sj.bmt.1703100
   PubMed Web of Science ®Google Scholar
• Cohen A, Doyle D, Martin Jr DW, Ammann AJ. (1976). Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med, 295(26), 1449–1454. doi:10.1056/NEJM197612232952603
   PubMed Web of Science ®Google Scholar
• Cohen A, Grunebaum E, Arpaia E, Roifman CM. (2000). Immunodeficiency caused by purine nucleoside phosphorylase deficiency. Immunol Allergy Clin, 20(1), 143–159. doi:10.1016/S0889-8561(05)70139-9
   Web of Science ®Google Scholar
• Cohen A, Gudas LJ, Ammann AJ, et al. (1978). Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest, 61(5), 1405–1409. doi:10.1172/JCI109058
   PubMed Web of Science ®Google Scholar
• Dalal I, Grunebaum E, Cohen A, Roifman C. (2001). Two novel mutations in a purine nucleoside phosphorylase (PNP)‐deficient patient. Clin Genet, 59(6), 430–437.
   PubMed Web of Science ®Google Scholar
• Delicou S, Kitra‐Roussou V, Peristeri J, et al. (2007). Successful HLA‐identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency. Pediatr Transplant, 11(7), 799–803. doi:10.1111/j.1399-3046.2007.00772.x
   PubMed Web of Science ®Google Scholar
• Diaz PS, Smith S, Hunter E, Arvin AM. (1988). Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. J Infect Dis, 158(6), 1245–1252.
   PubMed Web of Science ®Google Scholar
• Dror Y, Grunebaum E, Hitzler J, et al. (2004). Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology. Pediatr Res, 55(3), 472. doi:10.1203/01.PDR.0000111286.23110.F8
   PubMed Web of Science ®Google Scholar
• Fleischman A, Hershfield MS, Toutain S, et al. (1998). Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency. Clin Diagn Lab Immunol, 5(3), 399–400.
   PubMedGoogle Scholar
• Frey CR, Sharp MA, Min AS, et al. (2003). Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis, 188(1), 40–52. doi:10.1086/375828
   PubMed Web of Science ®Google Scholar
• Gelfand EW, Dosch H-M, Biggar WD, Fox IH. (1978). Partial purine nucleoside phosphorylase deficiency: studies of lymphocyte function. J Clin Invest, 61(4), 1071–1080. doi:10.1172/JCI109006
   PubMed Web of Science ®Google Scholar
• Giblett E, Ammann A, Sandman R, et al. (1975). Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet, 305(7914), 1010–1013. doi:10.1016/S0140-6736(75)91950-9
   Web of Science ®Google Scholar
• Girit S, Genel F, Can D, et al. (2012). Case of purine nucleoside phosphorylase deficiency presented with hematuria. Open J Pediatr, 2(04), 268. doi:10.4236/ojped.2012.24044
   Google Scholar
• Grunebaum E, Cohen A, Roifman CM. (2013). Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies. Curr Opin Allergy Clin Immunol, 13(6), 630–638. doi:10.1097/ACI.0000000000000006
   PubMed Web of Science ®Google Scholar
• Grunebaum E, Zhang J, Roifman CM. (2004). Novel mutations and hot‐spots in patients with purine nucleoside phosphorylase deficiency. Nucleosides Nucleotides Nucleic Acids, 23(8–9), 1411–1415. doi:10.1081/NCN-200027647
   PubMed Web of Science ®Google Scholar
• Gudas L, Zannis V, Clift S, et al. (1978). Characterization of mutant subunits of human purine nucleoside phosphorylase. J Biol Chem, 253(24), 8916–8924.
   PubMed Web of Science ®Google Scholar
• Hallett RJ, Cronin SM, Morgan G,et al. (1994). Normal uric acid concentrations in a purine nucleoside phosphorylase (PNP) deficient child presenting with severe chicken pox, possible immunodeficiency and developmental delay. In: Sahota A, Taylor MW, eds. Purine and Pyrimidine Metabolism in Man VIII. Boston, MA: Springer, 387–389.
   Google Scholar
• Hamet M, Griscelli C, Cartier P, et al. (1977). A second case of inosine phosphorylase deficiency with severe T-cell abnormalities. In: Müller MM, Kaiser E, Seegmiller JE, eds. Purine Metabolism in Man—II: Regulation of Pathways and Enzyme Defects. Boston, MA: Springer, 477–480.
   Google Scholar
• Hayward A, Giller R, Levin M. (1989). Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immunol, 2(3), 175–184. doi:10.1089/vim.1989.2.175
   PubMedGoogle Scholar
• Hayward AR. (1990). T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J Virol, 64(2), 651–655.
   PubMed Web of Science ®Google Scholar
• Kiykim A, Simsek IE, Kiykim E, et al. (2016). Two patients with novel missense mutation in the purine nucleoside phosphorylase gene without serious or recurrent infections. Clin Exp Neuroimmunol, 7(1), 79–82. doi:10.1111/cen3.12254
   Google Scholar
• Kumagai T, Chiba Y, Wafaya Y, et al. (1980). Development and characteristics of the cellular immune response to infection with varicella-zoster virus. J Infect Dis, 141(1), 7–13.
   PubMedGoogle Scholar
• Kumar A, Ziahosseini K, Saeed MU, et al. (2012). Bilateral viral retinitis in a patient with immune deficiency because of purine nucleoside phosphorylase deficiency. Retin Cases Brief Rep, 6(2), 153–155. doi:10.1097/ICB.0b013e318218f37e
   PubMedGoogle Scholar
• Levin MJ, Gershon AA, Weinberg A, et al. (2006). Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4+ T cells. J Infect Dis, 194(2), 247–255. doi:10.1086/505149
   PubMed Web of Science ®Google Scholar
• Madkaikar MR, Kulkarni S, Utage P, et al. (2011). Purine nucleoside phosphorylase deficiency with a novel PNP gene mutation: a first case report from India. BMJ Case Rep, 2011, bcr0920114804. doi:10.1136/bcr.09.2011.4804
   PubMedGoogle Scholar
• Markert ML. (1991). Purine nucleoside phosphorylase deficiency. Immunodefic Rev, 3(1), 45–81.
   PubMedGoogle Scholar
• Markert ML, Finkel BD, McLaughlin TM, et al. (1997). Mutations in purine nucleoside phosphorylase deficiency. Hum Mutat, 9(2), 118–121. doi:10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Markert ML, Hershfield M, Schiff R, Buckley R. (1987). Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients. J Clin Immunol, 7(5), 389–399.
   PubMed Web of Science ®Google Scholar
• Martin J, Sharma R, Nelson RP, et al. (2016 Mar 03). The first report of a pregnancy in a patient with purine nucleoside phosphorylase deficiency. Fetal Pediatr Pathol, 35(2), 120–123. doi:10.3109/15513815.2016.1139020
   PubMed Web of Science ®Google Scholar
• Mastrandrea LD. (2015 Nov 17). An overview of organ-specific autoimmune diseases including immunotherapy. Immunol Invest, 44(8), 803–816. doi:10.3109/08820139.2015.1099409
   PubMed Web of Science ®Google Scholar
• McGinniss MH, Wasniowska K, Zopf DA, et al. (1985 Mar-Apr). An erythrocyte Pr auto-antibody with sialoglycoprotein specificity in a patient with purine nucleoside phosphorylase deficiency. Transfusion, 25(2), 131–136.
   PubMed Web of Science ®Google Scholar
• McRoberts JA, Martin D. (1980). Submolecular characterization of a mutant human purine-nucleoside phosphorylase. J Biol Chem, 255(12), 5605–5615.
   PubMed Web of Science ®Google Scholar
• Moallem HJ, Taningo G, Jiang C, et al. (2002). Purine nucleoside phosphorylase deficiency: a new case report and identification of two novel mutations (Gly156A1a and Val217Ile), only one of which (Gly156A1a) is deleterious. Clin Immunol, 105(1), 75–80.
   PubMed Web of Science ®Google Scholar
• Myers LA, Hershfield MS, Neale WT, et al. (2004). Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr, 145(5), 710–712. doi:10.1016/j.jpeds.2004.06.075
   PubMed Web of Science ®Google Scholar
• Ozkinay F, Pehlivan S, Onay H, et al. (2007). Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections. J Child Neurol, 22(6), 741–743. doi:10.1177/0883073807302617
   PubMed Web of Science ®Google Scholar
• Pannicke U, Tuchschmid P, Friedrich W, et al. (1996). Two novel missense and frameshift mutations in exons 5 and 6 of the purine nucleoside phosphorylase (PNP) gene in a severe combined immunodeficiency (SCID) patient. Hum Genet, 98(6), 706–709.
   PubMed Web of Science ®Google Scholar
• Parvaneh N, Ashrafi M-R, Yeganeh M, et al. (2007). Progressive multifocal leukoencephalopathy in purine nucleoside phosphorylase deficiency. Brain Dev, 29(2), 124–126. doi:10.1016/j.braindev.2006.07.008
   PubMed Web of Science ®Google Scholar
• Parvaneh N, Teimourian S, Jacomelli G, et al. (2008). Novel mutations of NP in two patients with purine nucleoside phosphorylase deficiency. Clin Biochem, 41(4–5), 350–352.
   PubMed Web of Science ®Google Scholar
• Rich KC, Arnold WJ, Palella T, Fox IH. (1979). Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency. Am J Med, 67(1), 172–176.
   PubMed Web of Science ®Google Scholar
• Rich KC, Mejias E, Fox IH. (1980). Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions. N Engl J Med, 303(17), 973–977. doi:10.1056/NEJM198010233031705
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. (2015 May). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 17(5), 405–424. doi:10.1038/gim.2015.30
   PubMed Web of Science ®Google Scholar
• Rijksen G, Kuis W, Wadman SK, et al. (1987). A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics. Pediatr Res, 21(2), 137. doi:10.1203/00006450-198702000-00006
   PubMed Web of Science ®Google Scholar
• Sandman R, Ammann AJ, Grose C, Wara DW. (1977). Cellular immunodeficiency associated with nucleoside phosphorylase deficiency: immunologic and biochemical studies. Clin Immunol Immunopathol, 8(2), 247–253.
   PubMedGoogle Scholar
• Sasaki Y, Iseki M, Yamaguchi S, et al. (1998). Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient. Hum Genet, 103(1), 81–85.
   PubMed Web of Science ®Google Scholar
• Simmonds H, Fairbanks L, Morris G, et al. (1986). Erythrocyte GTP depletion in PNP deficiency presenting with haemolytic anaemia and hypouricaemia. Adv Exp Med Biol, 195, 481.
   PubMedGoogle Scholar
• Simmonds H, Fairbanks L, Morris G, et al. (1987). Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency. Arch Dis Child, 62(4), 385–391.
   PubMed Web of Science ®Google Scholar
• Simmonds HA, Watson AR, Webster DR, et al. (1982). GTP depletion and other erythrocyte abnormalities in inherited PNP deficiency. Biochem Pharmacol, 31(6), 941–946.
   PubMed Web of Science ®Google Scholar
• Somech R, Lev A, Grisaru-Soen G, et al. (2013). Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency. Immunol Res, 56(1), 150–154. doi:10.1007/s12026-012-8380-9
   PubMed Web of Science ®Google Scholar
• Somech R, Lev A, Simon AJ, et al. (2012). T-and B-cell defects in a novel purine nucleoside phosphorylase mutation. J Allergy Clin Immunol, 130(2), 539–542. doi:10.1016/j.jaci.2012.03.038
   PubMed Web of Science ®Google Scholar
• Soutar RL, Day RE. (1991). Dysequilibrium/ataxic diplegia with immunodeficiency. Arch Dis Child, 66(8), 982–983.
   PubMed Web of Science ®Google Scholar
• Stoop J, Eijsvoogel V, Zegers B, et al. (1976). Selective severe cellular immunodeficiency: effect of thymus transplantation and transfer factor administration. Clin Immunol Immunopathol, 6(3), 289–298.
   PubMedGoogle Scholar
• Stoop J, Zegers B, Hendrickx G, et al. (1977). Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med, 296(12), 651–655. doi:10.1056/NEJM197703242961203
   PubMed Web of Science ®Google Scholar
• Tabarki B, Yacoub M, Tlili K, et al. (2003). Familial spastic paraplegia as the presenting manifestation in patients with purine nucleoside phosphorylase deficiency. J Child Neurol, 18(2), 140–141. doi:10.1177/08830738030180021001
   PubMed Web of Science ®Google Scholar
• Tsuda M, Horinouchi K, Sakiyama T, Owada M. (2002). Novel missense mutation in the purine nucleoside phosphorylase gene in a Japanese patient with purine nucleoside phosphorylase deficiency. Pediatr Int, 44(3), 333–334.
   PubMed Web of Science ®Google Scholar
• Van Heukelom LS, Akkerman J, Staal G, et al. (1977). A patient with purine nucleoside phosphorylase deficiency: enzymological and metabolic aspects. Clin Chim Acta, 74(3), 271–279. doi:10.1016/0009-8981(77)90294-7
   PubMed Web of Science ®Google Scholar
• Virelizier J-L, Hamet M, Ballet -J-J, et al. (1978). Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defect. J Pediatr, 92(3), 358–362.
   PubMed Web of Science ®Google Scholar
• Walker P, Corrigan A, Arenas M, et al. (2011). Purine nucleoside phosphorylase deficiency: a mutation update. Nucleosides Nucleotides Nucleic Acids, 30(12), 1243–1247. doi:10.1080/15257770.2011.630852
   PubMed Web of Science ®Google Scholar
• Watson A, Evans D, Marsden H, et al. (1981). Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder. Arch Dis Child, 56(7), 563–565.
   PubMed Web of Science ®Google Scholar
• Watson AR, Simmonds HA, Webster DR, et al. (1984). Purine Nucleoside Phosphorylase (PNP) deficiency: A therapeutic challenge. In: De Bruyn CHMM, Simmonds HA, Müller MM, eds. Purine Metabolism in Man-IV: Part A: Clinical and Therapeutic Aspects; Regulatory Mechanisms. Boston, MA: Springer US, 53–59.
   Google Scholar
• Webster AD, Spickett GP, Thomson BJ, Farrant J. (1988 Apr). Viruses and antibody deficiency syndromes. Immunol Invest, 17(2), 93–105.
   PubMed Web of Science ®Google Scholar
• Williams SR, Gekeler V, McIvor R, Martin D. (1987). A human purine nucleoside phosphorylase deficiency caused by a single base change. J Biol Chem, 262(5), 2332–2338.
   PubMed Web of Science ®Google Scholar
• Williams SR, Goddard JM, Martin Jr DW. (1984). Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization. Nucleic Acids Res, 12(14), 5779–5787.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Moriwaki Y, Matsui K, et al. (1999). High IL-18 (interferon-γ inducing factor) concentration in a purine nucleoside phosphorylase deficient patient. Arch Dis Child, 81(2), 179–180.
   PubMed Web of Science ®Google Scholar
• Yeates L, Slatter MA, Gennery AR. (2017). Infusion of sibling marrow in a patient with purine nucleoside phosphorylase deficiency leads to split mixed donor chimerism and normal immunity. Frontiers Pediatrics, 5, 143. doi:10.3389/fped.2017.00143
   PubMed Web of Science ®Google Scholar
• Zabay J, De La Concha E, Ludeña C, et al. (1982). B cell hyperactivity and abnormalities in T cell markers and immunoregulatory function in a patient with nucleoside phosphorylase deficiency. Clin Exp Immunol, 50(3), 610.
   PubMed Web of Science ®Google Scholar